The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...
A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
Each Part D plan has a formulary that lists all of the drugs that it covers, including generic and brand name ... A person enrolled in Original Medicare (Part A and Part B) is eligible to get ...
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results